Papers
3
Total Citations
58
H-Index
3
About
Dr. Scott Greenberg is a urologic surgeon and researcher whose work centers on improving surgical outcomes for prostate cancer patients, with a particular focus on precision oncology and postoperative quality of life. His most impactful contribution is leading the first-in-human evaluation of IS-002, a novel near-infrared fluorescent small molecule targeting prostate-specific membrane antigen (PSMA). This groundbreaking study, published in 2023 and already garnering 35 citations, demonstrated the potential for real-time, fluorescence-guided identification of prostate cancer during robotic-assisted prostatectomy, a significant step toward reducing positive surgical margins and improving cancer control. Dr. Greenberg has also made important contributions to understanding postoperative urinary continence, showing in a 2022 study (17 citations) that preoperative membranous urethral length is a key predictor of recovery after robot-assisted radical prostatectomy. Additionally, his 2021 investigation into residual benign prostate tissue after surgery clarified that such findings are not linked to detectable postoperative PSA or biochemical recurrence, helping to refine patient counseling and follow-up protocols. Through these studies, Dr. Greenberg is advancing both the technical precision and the patient-centered outcomes of prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3